0000805928-22-000013.txt : 20220217
0000805928-22-000013.hdr.sgml : 20220217
20220217161126
ACCESSION NUMBER: 0000805928-22-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scopelianos Angelo
CENTRAL INDEX KEY: 0001751541
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 22648179
MAIL ADDRESS:
STREET 1: C/O AXOGEN, INC.
STREET 2: 13631 PROGRESS BOULEVARD - SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_164513225128430.xml
FORM 4
X0306
4
2022-02-15
0
0000805928
Axogen, Inc.
AXGN
0001751541
Scopelianos Angelo
13631 PROGRESS BOULEVARD
SUITE 400
ALACHUA
FL
32615
0
1
0
0
Chief R&D Officer
Common Stock
2022-02-15
4
A
0
1325
0
A
12350
D
Common Stock
2022-02-15
4
F
0
400
8.42
D
11950
D
This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.
Includes 41 shares acquired under the Axogen stock purchase plan on December 31, 2021.
The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022.
/s/ Angelo Scopelianos
2022-02-17